Change institution

Tomáš Reigl

Email:
Phone: +420 54949 7428
Research Group: Medical Genomics - Šárka Pospíšilová

2017

  • BYSTRY, V.; REIGL, T; KREJCI, A; DEMKO, M; HANAKOVA, B; GRIONI, A; KNECHT, H; SCHLITT, M.; DREGER, P; SELLNER, L;HERRMANN, D; PINGEON, M; BOUDJOGHRA, M; RIJNTJES, J; POTT, C; LANGERAK, A W; GROENEN P. J; DAVI, F; BRÜGGEMANN, M; DARZENTAS, N, 2017:ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data. 33 (3), p. 435 - 437.
  • PAL, K; BYSTRY, V; REIGL, T; DEMKO, M; KREJCI, A; TOULOUMENIDOU, T; STALIKA, E; TICHY, B; GHIA, P; STAMATOPOULOS, K; POSPISILOVA, S; MALCIKOVA, J; DARZENTAS, N, 2017:GLASS: assisted and standardized assessment of gene variations from Sanger sequence trace data. BIOINFORMATICS 33 (23), p. 3802 - 3804.

2016

  • GRIONI, A; FAZIO, G; REIGL, T; RIGAMONTI, S; BYSTRY, V; SONGIA, S; BIONDI, A; DARZENTAS, N; CAZZANIGA, G, 2016:A PLATFORM FOR DETECTION OF FUSION GENES IN ALL FROM TARGET CAPTURE NEXT- GENERATION SEQUENCING OF DNA AND RNA. HAEMATOLOGICA 101 , p. 26 - 27.

2015

  • SELLNER, L; DREGER, P; SCHLITT, M; KNECHT, H; HERRMANN, D; REIGL, T; KREJCI, A; BYSTRY, V; DARZENTAS, N; RIEGER, M; DIETRICH, S; ZENZ, T; HO, AD; KNEBA, M; BRUEGGEMANN, M, 2015:T-Prolymphocytic Leukemia Is Sensitive to Polyclonal T Cell-Derived Graft-Versus-Leukemia Effects: Evidence from Minimal Residual Disease Kinetics and TCR Repertoire Diversity Analyses. BLOOD 126 (23)
Office 1:
Masarykova univerzita - CEITEC MU Kamenice 753/5, Brno, 625 00, office bud. A35/215
More CEITEC News ...
Dr. Ondrej Hovorka: Models of magnetic nanoparticles for biomedical applications

29. ledna 2018 9:46

Dr. Ondrej Hovorka: Models of magnetic nanoparticles for biomedical…

LECTURE: Dr. Ondrej Hovorka: Models of magnetic nanoparticles for biomedical applications

Advanced Materials and Nanotechnology Seminar Series 2018: Dr Andriy Marko

25. ledna 2018 18:21

Advanced Materials and Nanotechnology Seminar Series 2018: Dr Andriy…

WHEN: 30. 01. 2018 WHERE: CEITEC BUT, Purkynova 123, large meeting room SPEAKER: Dr Andriy Marko TALK: Advances in PELDOR…